Preferential radiosensitization of mouse sarcoma relative to normal skin by chronic intra-arterial infusion of halogenated pyrimidine analogs.
D000818:Animals; D001966:Bromine / Q000008:administration & dosage; D002247:Carbon Isotopes; D002845:Chromatography; D003596:Cytosine / Q000008:administration & dosage*; D004273:DNA, Neoplasm / Q000032:analysis; D005467:Floxuridine / Q000494:pharmacology; D007269:Injections, Intra-Arterial; D051379:Mice; D009368:Neoplasm Transplantation; D009705:Nucleosides / Q000008:administration & dosage*; D011830:Radiation Effects; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage*; D011879:Radiotherapy Dosage; D012513:Sarcoma, Experimental / Q000532:radiotherapy*; D012867:Skin / Q000187:drug effects* / Q000528:radiation effects; D014316:Tritium
D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D009705:Nucleosides; D011838:Radiation-Sensitizing Agents; D005467:Floxuridine; D014316:Tritium; D003596:Cytosine; D001966:Bromine